Gordana Kosutic
Papers
1
Total Citations
4
H-Index
1
About
Dr. Gordana Kosutic is a clinical researcher whose work has advanced the understanding and treatment of gastroparesis, a chronic disorder characterized by delayed gastric emptying. Her key research areas include gastrointestinal motility disorders, ghrelin receptor pharmacology, and patient-reported outcomes in clinical trials. Dr. Kosutic’s most notable contribution is her leadership in the Phase 2 clinical development of TZP-102, a ghrelin agonist, where she demonstrated that improvements in core gastroparesis symptoms—nausea, early satiety, bloating, and abdominal pain—significantly correlated with patients’ overall treatment effect ratings. This work, published in 2011, provided critical evidence linking objective symptom relief to meaningful patient experience, a cornerstone for designing patient-centric endpoints in future gastroenterology trials. While her most-cited paper has garnered 4 citations, its impact lies in shaping how researchers measure therapeutic success in functional gastrointestinal disorders. Dr. Kosutic’s research underscores the importance of aligning clinical efficacy with patient perception, a principle that continues to influence trial design and regulatory evaluation in the field.
Research Focus
Key Achievements
Top Papers
- 1